Conference Coverage

Escalate HIV adherence strategies amid COVID-19


 

Stigma on stigma

The need for this level of support from the clinic may be even more important for people with HIV who acquire COVID-19, said Orlando Harris, PhD, assistant professor of community health systems at the University of California, San Francisco, (UCSF) School of Nursing. HIV-related stigma is a well-known deterrent to care for people living with the virus. During the presentation, Harris asked Farley about the impact of COVID-19 stigma on people with both HIV and COVID-19.

Farley said that patients at his clinic have told him that they have “ostracized” friends who have tested positive for COVID-19. Harris remembered a person with HIV who participated in one of his trials telling the researchers that despite all his precautions – wearing a mask, staying socially distant – he still acquired COVID-19. There was nothing he could have done, Harris said, other than just not go to the grocery store.

The fear of contracting another disease that is associated with stigma, as well as the need to disclose it, can inflame memories of the trauma of being diagnosed with HIV, Harris said. And with patient-centered medical homes struggling to reconstitute their wraparound services via telehealth, he said he wonders whether clinicians should be doing more.

“I worry about people who have survived being diagnosed with HIV in the ‘80s and the ‘90s before antiretroviral therapy showed up on the scene,” he told Medscape Medical News. “I worry that the folks that survived one pandemic [may] be feeling fearful or living in that fear that this new pandemic might take them out. That’s why I’m stressing the need for us to really consider, as clinicians and also as researchers the support systems, the coping mechanisms, the counseling, or what have you to support those living with HIV and vulnerable to COVID-19.”

During telehealth visits, that can be achieved simply by asking people how they are really doing and what their coping mechanisms are.

For their part, the clinicians at San Francisco’s Ward 86 are not trying to provide that support through telehealth on the same level as they were at the beginning of the pandemic, said Matthew Spinelli, MD, assistant professor of medicine, and Monica Gandhi, MD, associate chief of the Division of HIV, Infectious Diseases and Global Medicine, who are both at UCSF and are coauthors of the study.

They still offer telemedicine appointments to patients who request them, said Spinelli. He said about one-third of his patients still prefer to receive their care virtually. The rest have gone back to face-to-face support.

“The analysis led us to promptly open up care as much as possible to our patients, with the idea that telehealth is not cutting it for vulnerable patients with HIV,” Gandhi told Medscape Medical News via email. “We don’t think it’s right for a population who relies on social support from the clinic.”

This article first appeared on Medscape.com.

Pages

Recommended Reading

What happened to melanoma care during COVID-19 sequestration
MDedge Endocrinology
Moral distress: COVID-19 shortages prompt tough decisions at bedside
MDedge Endocrinology
Search for a snakebite drug might lead to a COVID treatment, too
MDedge Endocrinology
Patients with mental illness a priority for COVID vaccine, experts say
MDedge Endocrinology
Should our patients really go home for the holidays?
MDedge Endocrinology
Nearly 10% of hospitalized patients with COVID-19 later readmitted
MDedge Endocrinology
AMA creates COVID-19 CPT codes for Pfizer, Moderna vaccines
MDedge Endocrinology
New reports guide return to play in athletes with COVID-19
MDedge Endocrinology
Nearly one in five develop mental illness following COVID-19
MDedge Endocrinology
Situation ‘dire’ as COVID spike in West, Midwest worsens, experts say
MDedge Endocrinology